United States President Donald Trump on Friday announced a fresh wave of tariff on products like the branded or patented drugs, which are not made in the US and imported into the country will face a 100 per cent tariff starting October 1, 2025.

However, he said that the companies which are building facilities in the US will be exempted from the fresh tariff. Trump announcing the decision to slap tariff on his Truth Social defined this as companies either \"breaking ground\" or being \"under construction\".

Trump has long maintained that tariffs are the key to forcing companies to invest more in domestic factories.

What this means for Indian industry?

Many large Indian pharma companies derive between 40 - 50 per cent of their total revenue from the US market, according to reports.

Thus

See Full Page